Back to the Beginning: Understanding mechanisms regulating human intervertebral disc development and their dysregulation in degenerative disease using an integrated multi-omic approach (360G-Wellcome-331854_Z_25_Z)

£310,038

Intervertebral disc (IVD) degeneration is a leading cause of chronic low back pain and disability, impacting millions of people worldwide. The IVD is made up of a central nucleus pulposus (NP) surrounded by an annulus fibrosus and is essential for flexibility and movement. During development, the NP is populated by notochordal cells, and these are replaced by chondrocyte cells by adolescence. Loss of notochordal cells coincides with the onset of degeneration, suggesting that early signals are essential for disc homeostasis. While most research focuses on end-stage degeneration, early events driving the onset of disease in humans remain poorly understood. As a result, current therapies lack long-term efficacy, and we need better treatments for disc degeneration. Preliminary transcriptomic data revealed that specific genes are upregulated during development, repressed in maturation and reactivated during degeneration, suggesting a dysregulation of developmental mechanisms. SPP1 (secreted phosphoprotein-1) is one such gene and has been selected as a candidate for analysis. This proposal aims to elucidate the function and mechanisms regulating SPP1 in human IVD development and how dysregulation contributes to degeneration. I will apply an integrated workflow combining long-read sequencing, ATAC-sequencing, proteomics, bioinformatics, gene-editing and biofabrication to define these mechanisms, revealing potential targets for regeneration.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Region North West
Award Date 2025-11-05T00:00:00+00:00
Internal ID 331854/Z/25/Z
Planned Dates: End Date 2028-11-30T00:00:00+00:00
Planned Dates: Start Date 2026-12-01T00:00:00+00:00
Amount Awarded 310038
Financial Year 2025/26
Lead Applicant Dr Christabel Thembela Dube
Grant Programme: Title Wellcome Accelerator Awards
Applicant Surname Dube
Approval Committee Accelerator Awards Advisory Committee
Recipient Org: Country United Kingdom
Recipient Org: City Manchester
Has the grant transferred? No
Research conducted at multiple locations? Yes
Total amount including partnership funding 310038

Help shape the next 10 years of GrantNav!

GrantNav is celebrating its 10th anniversary. Take our quick 3-minute survey to tell us how we can make the data work better for you.

Take the Survey